Occurrence of Selected HCPCS Codes 2

    Basic Details
    Date Posted
    Thursday, August 2, 2012
    Status
    Complete
    Medical Product
    busulfan
    chlorambucil
    cyclophosphamide
    finasteride
    methotrexate
    trastuzumab
    Description

    Summary table assessment of the prevalence of 12 procedure codes in the Mini-Sentinel Distributed Database using Healthcare Common Procedure Coding System (HCPCS) codes, specifically "Injection busulfan 1 MG" (HCPCS code J0594), "Busulfan; oral 2 MG" (HCPCS code J8510), "Cyclophosphamide oral 25 MG" (HCPCS code J8530), "Methotrexate oral 2.5 MG" (HCPCS code J8610), "Cyclophosphamide lyophilized 100 MG" (HCPCS code J9093), "Cyclophosphamide lyophilized 200 MG" (HCPCS code J9094), "Cyclophosphamide lyophilized 500 MG" (HCPCS code J9095), "Cyclophosphamide lyophilized 1 G" (HCPCS code J9096), "Cyclophosphamide lyophilized 2 G" (HCPCS code J9097), "Injection trastuzumab 10 MG" (HCPCS code J9355), "Finasteride 5 MG" (HCPCS code S0138), and "Chlorambucil oral 2 MG" (HCPCS code S0172). Results were generated using the Mini-Sentinel Distributed Query Tool and the HCPCS Summary Table. Summary tables are precompiled stratified counts. Queries were run in the outpatient setting. Queries were executed in November 2011. This report includes data from 13 Data Partners.

     This document is an Excel spreadsheet that includes multiple layers of data configured using pivot tables. If you do not have Excel, click here to obtain a free version of Microsoft’s Excel Viewer.

     If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

     The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    CDER
    Time Period
    2004 - 2010
    Study Type
    Summary Table
    Assessment Type
    Exploratory Analyses
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)